¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"marginal granulocyte pool"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® granulocyte ÇÑ±Û °ú¸³±¸
¼³¸í   
  °ú¸³±¸¶õ ÀûÇ÷±¸¸¦ Á¦¿ÜÇÑ Ç÷¾×¼ÓÀÇ ¼¼Æ÷ÀΠ¹éÇ÷±¸ÀÇ 60%¸¦ Â÷ÁöÇϸç, ¼¼Æ÷¼Ó¿¡ Æ¯ÀÌÇÑ °ú¸³À» °¡Áö°í Àִ ¼¼Æ÷À̸ç, ´ÙÀ½°ú °°Àº 3°¡ÁöÀÇ ¼¼Æ÷°¡ À̰÷¿¡ Æ÷ÇÔÀÌ µÈ´Ù.
  
  1. È£¿°±â±¸(basophil)-¿°±â¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ´Ù. ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÇ ¼¼Æ÷·Î Çª¸¥»öÀ» ¶ì´Â °ú¸³ÀÌ ³Ê¹« ¸¹ÀÌ À־ ÇÙÀÌ Àß º¸ÀÌÁö ¾Ê´Â´Ù.
  
  2. È£»ê±¸(eosinophil)-»ê¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ°í, ´ë°³ ±â»ýÃæÀÇ °¨¿°À̳ª, ¾Ë·¹¸£±â¿¡¼­ ¸¹ÀÌ Áõ°¡¸¦ ÇÑ´Ù. ´ë°³ 2°³ÀÇ ÇÙÀ» °¡Áö°í ÀÖÀ¸¸ç ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº °ÍÀ¸·Î À̾îÁ® ÀÖ´Ù.
  
  3. È£Áß±¸(neutrophil)-»ê¼º ¿°»ö¾àÀ̳ª ¿°±â¼º ¿°»ö¾àÀ̳ª ¸ðµÎ Àß µÇ´Â °ú¸³À» °¡Áö´Â ¼¼Æ÷·Î ´ë°³ 3°³ÀÇ ÇÙÀ» °¡Áø´Ù. ±×¸®°í ÇÙ »çÀÌ¿¡ °¡´Â ½Ç°°Àº ±¸Á¶¹°ÀÌ À־ ÇÙÀ» ¼­·Î À̾îÁÖ°í ÀÖ´Ù.
  
  ÀÌ °ú¸³±¸´Â ÁַΠ¸é¿ª¿¡ °ü°èµÈ ¿ªÇÒÀ» Çϴ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. 
¿µ¹® segmented granulocyte ÇÑ±Û ºÐÀý °ú¸³±¸
¼³¸í   
  °ú¸³±¸(¼¼Æ÷Áú³»¿¡ Á¡°°Àº °ú¸³À» Æ÷ÇÔÇϴ ¼¼Æ÷)Áß ¸»ÃÊ Ç÷¾×À» ¼øÈ¯Çϴ ¼º¼÷µÈ °ú¸³±¸·Î ÇÙÀÇ ¸ð¾çÀÌ µÎ °³ ÀÌ»óÀÇ ºÐÀýÀ» ÀÌ·ç°í ÀÖ´Ù. ¿©±â¿¡´Â ±× ¿°»ö»óÀÇ ¹æ¹ý¿¡ µû¶ó È£Áß±¸(Áß¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£»ê±¸(»ê¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£¿°±¸(¿°±â¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ)·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood pool scan
    Ç÷¾×¿õµ¢À̽ºÄµ, Ç÷¾×Àú·ù½ºÄµ
  • gated blood pool scanning
    °¡µÐÇ÷¾×¿õµ¢À̽ºÄ³´×
  • gene pool
    À¯ÀüÀÚÇ®
  • pool
    ¿õµ¢ÀÌ, Ç®
  • swimming pool granuloma
    ¼ö¿µÀåÀ°¾ÆÁ¾
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸, È£¿°±â°ú¸³±¸
  • granulocyte
    °ú¸³¹éÇ÷±¸, °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ, °ú¸³±¸´ë½Ä±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • marginal
    1. ¸ð¼­¸®-, ¿¬- 2. °¡ÀåÀÚ¸®-, °æ°è-
  • marginal alopecia
    °¡ÀåÀÚ¸®Å»¸ð(Áõ)
  • marginal artery
    ¸ð¼­¸®µ¿¸Æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pool
    ¿õµ¢ÀÌ, Ç®
  • granulocyte
    °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸
  • marginal
    ¸ð¼­¸®-
  • marginal ulcer
    °¡ÀåÀÚ¸®±Ë¾ç, º¯¿¬±Ë¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte
    °ú¸³¹éÇ÷±¸
  • blood pool scan
    Ç÷¾×¿õµ¢À̽ºÄµ, Ç÷¾×Àú·ù½ºÄµ
  • gated blood pool scanning
    °¡µÐÇ÷¾×¿õµ¢À̽ºÄ³´×
  • gene pool
    À¯ÀüÀÚÇ®
  • swimming pool granuloma
    ¼ö¿µÀåÀ°¾ÆÁ¾
  • internuncial pool theory
    ½Å°æ¼¼Æ÷»çÀÌÀúÀå·Ð
  • motor neuron pool
    ¿îµ¿½Å°æ¼¼Æ÷Áý´Ü
  • pool
    ¿õµ¢ÀÌ, Ç®
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í
  • marginal alopecia
    °¡ÀåÀÚ¸®Å»¸ðÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Terriens marginal degeneration
    Å׸®¿£º¯¿¬°¢¸·º¯¼º
  • inner marginal epithelium
    ³»¿¬»óÇÇ.
  • hypothermia pool
    Àúü¿ÂǪ¿ï.
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í.
  • pool
    Ç®
  • pool conjunctivitis
    Ǫ¿ï¼º °á¸·¿°(¡­àõ ̿دæú), ¼ö¿µÀå°á¸·¿°(â©ç¶íÞ̿دæú)
  • pool sanitation
    Ǫ¿ï À§»ý(ÊÙËôË×).
  • G-CSF (Granulocyte colony-stimulating factor)
    °ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í­)
  • granulocyte
    °ú¸³¹éÇ÷__¡­ÛÜúìϹ), °ú¸³__
  • granulocyte
    °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte colony-stimulating factor=G-CSF
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte source
    °ú¸³±¸¿øÃµ<--±Ù¿ø
  • granulocyte transfusion
    °ú¸³¼¼Æ÷ ¼öÇ÷
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • marginal granulocyte pool
    º¯¿¬¼º °ú¸³±¸Çª¿ï
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circulating granulocyte pool
    ¼øÈ¯ °ú¸³¹éÇ÷±¸ Ǫ¿ï
  • blood pool scan
    Ç÷¾× Ǫ¿ï ÁÖ»ç(úìäû - ñ¼ÞÒ).
  • blood pool scan
    Ç÷¾×Àú·ùÁÖ»ç.
  • common metabolic pool
    °øÀ¯´ë»çÇ®.
  • hypothermia pool
    Àúü¿ÂǪ¿ï.
  • metabolic pool
    ´ë»çǪ¿ï.
  • motor neuron pool
    ¿îµ¿´º¿ì·ÐÁý´Ü(ê¡ÔÑ¡­ó¢Ó¥).
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í.
  • pool
    Ç®
  • pool conjunctivitis
    Ǫ¿ï¼º °á¸·¿°(¡­àõ ̿دæú), ¼ö¿µÀå°á¸·¿°(â©ç¶íÞ̿دæú)
  • pool sanitation
    Ǫ¿ï À§»ý(ÊÙËôË×).
  • storage pool
    ÀúÀåǪ¿ï.
  • storage pool disease
    ÀúÀåÇ®º´(ÀúÀåǮܻ)
  • swimming pool conjuntivitis
    ¼ö¿µÀå°á¸·¿° (â©ç¶íÞ̿دæú)
  • swimming pool granuloma
    ¼ö¿µÀåÀ°¾ÆÁ¾ (¡­ë¿ä´ðþ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Marginal tubercle)
    (¸ð¼­¸®°áÀý)
    [¿¾ ¿ë¾î] ¸é°áÀý
  • Marginal area
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬ºÎ
  • Marginal zone
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬´ë
  • Marginal sinus
    °¡ÀåÀÚ¸®µ¿±¼
    [¿¾ ¿ë¾î] º¯¿¬µ¿
  • Marginal part
    °¡ÀåÀÚ¸®ºÎºÐ
    [¿¾ ¿ë¾î] ¿¬ºÎ
  • Marginal insertion
    °¡ÀåÀÚ¸®ºÎÂø
    [¿¾ ¿ë¾î] º¯¿¬ºÎÂø
  • Marginal sinus
    °¡ÀåÀÚ¸®Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] º¯¿¬µ¿
  • Marginal layer
    °¡ÀåÀÚ¸®Ãþ
    [¿¾ ¿ë¾î] º¯¿¬Ãþ
  • Marginal placenta
    °¡ÀåÀÚ¸®Å¹Ý
    [¿¾ ¿ë¾î] º¯¿¬¼ºÅ¹Ý
  • Lateral marginal vein
    °¡Âʸ𼭸®Á¤¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬Á¤¸Æ
  • Marginal crest
    ¸ð¼­¸®´É¼±
    [¿¾ ¿ë¾î] º¯¿¬´É
  • Marginal papilla
    ¸ð¼­¸®À¯µÎ
    [¿¾ ¿ë¾î] ¿¬À¯µÎ
  • Marginal sinus
    ¸ð¼­¸®Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ¿¬Á¤¸Æµ¿
  • Medial marginal vein
    ¾ÈÂʸ𼭸®Á¤¸Æ
    [¿¾ ¿ë¾î] ³»Ãø¿¬Á¤¸Æ
  • Right marginal branch
    ¿À¸¥¸ð¼­¸®°¡Áö
    [¿¾ ¿ë¾î] ¿ì¿¬Áö
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • marginal ring
    Ç¥¸é¹ÝÁöÇü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate pool
    ¾Æµ¥´Ò»ê(ß«) Ç®
  • gene pool
    À¯ÀüÀÚ(ë¶îîí­) Ç®
  • metabolic pool
    ´ë»ç(ÓÛÞó) Ç®
  • pool
    Ç®
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood pool scan
    Ç÷¾×Àú·ùÁÖ»ç
  • pool
    Ç®
  • vascular pool
    Ç÷°üÇ®
  • marginal
    ¸ð¼­¸®ÀÇ, ¿¬º¯ÀÇ
  • marginal artery
    ¸ð¼­¸®µ¿¸Æ, ¿¬º¯µ¿¸Æ
  • marginal echo
    °¡ÀåÀÚ¸®¿¡ÄÚ, ÁÖº¯¿¡ÄÚ
  • marginal ray
    ÁÖº¯¼±
  • marginal ulcer
    ¿¬º¯±Ë¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MGP marginal granulocyte pool; marginating granulocyte pool; membranous glomerulonephropathy; mucin glyc...
CGP N-carbobenzoxy-glycyl-L-phenylalanine; chorionic growth hormone-prolactin; choline glycerophosphatid...
PMA index of prevalence and severity of gingivitis, where P = papillary gingiva, M = marginal gingiva, a...
MP   1) Marginal Pool
  2) Metacarpal Phalangeal
TBGP total blood granulocyte pool
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GBP Gated blood pool
SPD storage pool deficiency
GM-CSF Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor
G-CSF Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor
MB marginal band
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood pool scan
    Ç÷¾× Àú·ù ÁÖ»ç
  • circulating pool
    ¼øÈ¯ Ç®
  • marginated pool
    º¯¿¬ Ç®
  • Na pool
    ¼Òµð¿ò Ç®
  • pool
    Ç®
  • proliferating cell pool

    proliferating pleurisy (Áõ½Ä¼º È丷¿°

  • storage pool disease
    ÀúÀåÁ¶º´
    ÀÀÁýÁ¦, ¿¡Çdz×ÇÁ¸°, ¿ÜÀμº ADP, Æ®·Òºó µî¿¡ ¹ÝÀÀÇÏ¿© ADP¸¦ ¹æÃâÇÏ´Â Ç÷¼ÒÆÇ ±â´É ºÎÀü¿¡ ÀÇÇÑ Ç÷¾× ÀÀ°í Àå¾Ö, °¡º­¿î ÃâÇ÷ Áõ»ó, ÃâÇ÷ ½Ã°£ Áö¿¬, ±³¿øÁúÀ̳ª Æ®·Òºó¿¡ ´ëÇÑ ÀÀÁý ¹ÝÀÀÀÇ °¨Å𸦠Ư¡À¸·Î ÇÑ´Ù.
  • chronic marginal gingivitis
    ¸¸¼º º¯¿¬ Ä¡Àº¿°, ¸¸¼º º¯¿¬¼º Ä¡Àº¿°
  • left marginal branch
    ¿Þ ¸ð¼­¸® °¡Áö
  • marginal
    º¯¿¬ÀÇ
    °¡ÀåÀÚ¸®ÀÇ.
  • marginal artery
    ¸ð¼­¸® µ¿¸Æ, ¿¬º¯ µ¿¸Æ
  • marginal bevel angle
    ¿Í¿¬ °æ»ç°¢
  • marginal closure
    ¿¬º¯ ºÀ¼â
  • marginal degradation
    º¯¿¬ ºØ±«
  • marginal echo
    °¡ÀåÀÚ¸® ¿¡ÄÚ, ÁÖº¯ ¿¡ÄÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptors, granulocyte-colony-stimulating factor Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
(12 Dec 1998)
receptors, granulocyte-macrophage colony-stimulating factor Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
(12 Dec 1998)
granulocyte <haematology> Leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils (using a Romanovsky type stain), some invertebrate blood cells are also referred to, not very helpfully, as granulocytes.
(12 Dec 1998)
granulocyte-colony-stimulating factor <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds.
It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines.
A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy.
See: colony-stimulating factor.
Acronym: G-CSF
(12 Dec 1998)
granulocyte-macrophage colony-stimulating factor <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds.
It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation.
It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages.
It is used to promote the recovery of the white blood cells following chemotherapy.
Chemical name: Colony-stimulating factor 2
See: colony-stimulating factor.
Acronym: GM-CSF
(12 Dec 1998)
immature granulocyte An immature neutrophil, except that it may be neutrophilic, acidophilic, or basophilic in character.
(05 Mar 2000)
abdominal pool The volume of blood within the abdomen.
(05 Mar 2000)
blood pool imaging Nuclear medicine study using a radionuclide that is confined to the vascular compartment.
(05 Mar 2000)
cardiac blood pool imaging This noninvasive test uses radioactive tracers to delineate the hearts chambers and major vessels. It may be used to detect a heart attack, heart muscle function and coronary artery disease. The patient receives a radioactive tracer by injection (into a vein) and then the heart is imaged using a gamma camera. The heart is imaged before and after exercise. This test may be used to detect and evaluate atrial septal defect, dilated cardiomyopathy, congestive heart failure, cardiomyopathy, Lyme disease (secondary), mitral stenosis and superior vena cava syndrome.
(27 Sep 1997)
vaginal pool The secretions and material that accumulate in the posterior fornix of the vagina; used for sampling, principally for evaluation after premature rupture of the membranes.
(05 Mar 2000)
gated blood pool imaging Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchroniser or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography (ventriculography, first-pass).
(12 Dec 1998)
gene pool The total sum of genetic information present in a population at anygiven moment.
(09 Oct 1997)
granuloma, swimming pool Localised nodular skin inflammation (small reddish raised areas of skin) caused by a bacterium called mycobacterium marinum. Swimming pool granuloma is typically acquired by occupational or recreational exposure to salt or fresh water, often resulting from minor trauma during caring for aquariums. The diagnosis is suggested by the history of exposure and confirmed by culturing tissue specimens which yield the microscopic organism, mycobacterium marinum. The infection can be treated with a variety of antibiotics, including doxycycline, minocycline, clarithromycin, rifampin, and trimethoprim-sulfamethoxazole. Also called fish bowl granuloma.
(12 Dec 1998)
metabolic pool The quantity of a given chemical compound or group of related compounds participating in metabolic reactions; may constitute only a portion of the total bodily content of such compounds.
(05 Mar 2000)
platelet storage pool deficiency A group of disorders characterised by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5ht are normally stored.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte
    °ú¸³¼º ¹éÇ÷±¸;°ú¸³±¸
  • marginal
    ³ª¿Ü¿¡ ¾´
  • marginal
    ¾ðÀú¸®ÀÇ;°¡ÀÇ;ÇѰ迡 °¡±î¿î;³­¿ÜÀÇ
  • marginal land
    (ºÒ¸ð¿¡ °¡±î¿î) ¸Þ¸¶¸¥ °æÀÛÁö
  • marginal man
    (»ç) (µÎ ¹®È­ÀÇ) °æ°èÀÎ
  • marginal notes
    ¹æÁÖ
  • marginal sea
    ¿µÇØ
  • marginal utility
    ÇѰè È¿¿ë
  • pool
    ¹°¿õµ¢ÀÌ
  • car pool
    (ÀÚ°¡¿ëÂ÷ÀÇ)ÇÕ½ÂÀÌ¿ë(±×·ì) (Åë±Ù µî¿¡¼­ ±³´ë·Î ÀÚ±â Â÷¿¡ Å¿öÁÖ±â
  • dirty pool
    Ä¡»çÇÑ ÇàÀ§;ºÎÁ¤ÇÑ ¹æ¹ý
  • football pool
    Dzº¼ µµ¹Ú
  • gene pool
    À¯ÀüÀÚ Ç®;À¯ÀüÀÚ °ø±Þ¿ø(¸àµ¨ Áý´ÜÀ» ±¸¼ºÇÏ´Â ¸ðµç °³Ã¼°¡ °¡Áö°í ÀÖ´Â À¯ÀüÀÚ Àüü)
  • moon pool
    ¹®Ç®(½ÉÇØ ±¼Âø¼± Áß¾ÓÀÇ ¿øÅë»ó°øµ¿ ¼³ºñ,±âÀ縦 ¿À¸£³»¸®´Â °÷)
  • motor pool
    ¹èÂ÷¿ë ÀÚµ¿Â÷±º;ÁÖÂ÷Àå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á